Cargando…

Safety of treatment with biologics for psoriasis in daily practice: 5-year data

Detalles Bibliográficos
Autores principales:	Van Lümig, PPM, Driessen, RJB, Berends, MAM, Boezeman, J B, van de Kerkhof, PCM, de Jong, EMGJ
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007758/ http://dx.doi.org/10.1186/1479-5876-8-S1-P16

Ejemplares similares

Implementing intensive insulin therapy in daily practice reduces the incidence of critical illness polyneuropathy and/or myopathy
por: Berends, N, et al.
Publicado: (2008)

Quality of life, treatment goals, preferences and satisfaction in older adults with psoriasis: a patient survey comparing age groups
por: van Winden, M.E.C., et al.
Publicado: (2020)

Highlights of the updated Dutch evidence‐ and consensus‐based guideline on psoriasis 2017
por: van der Kraaij, G.E., et al.
Publicado: (2019)

Frailty screening in dermato‐oncology practice: a modified Delphi study and a systematic review of the literature
por: van Winden, M.E.C., et al.
Publicado: (2020)

Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice
por: van der Schoot, L.S., et al.
Publicado: (2023)

RECIST criteria: our experience in daily practice
por: De Luca, S, et al.
Publicado: (2015)

A European subset analysis from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country‐specific features: results from psoriasis patients in Spain
por: Puig, L., et al.
Publicado: (2017)

T1 mapping in daily CMR practice
por: Nadjiri, Jonathan, et al.
Publicado: (2014)

Pioneers in Dermatology and Venereology: An Interview with Professor Peter van de Kerkhof
por: van de Kerkhof, P.C.M.
Publicado: (2021)

Optimizing shared decision making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic
por: van Winden, M.E.C., et al.
Publicado: (2021)

2-year outcome of juvenile idiopathic arthritis in current daily practice: what can we tell our patients?
por: Anink, Janneke, et al.
Publicado: (2011)

ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults
por: Orkin, C, et al.
Publicado: (2010)

Efficacy and safety of once daily dosing of colistin to critically ill patients
por: Skiada, A, et al.
Publicado: (2010)

Glycemic control in critically ill infants and children: achieved quality of control in daily clinical practice in Leuven after a RCT
por: Voets, E, et al.
Publicado: (2011)

Quality of life outcomes in adults with moderate‐to‐severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study
por: van de Kerkhof, P.C.M., et al.
Publicado: (2019)

Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey
por: van de Kerkhof, P.C.M., et al.
Publicado: (2015)

Safety and efficacy of a nurse-driven sedation protocol with daily sedation interruption in the ICU
por: Chan, KP, et al.
Publicado: (2010)

Pharmacokinetic (PK) and pharmacodynamic analyses of once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial
por: Sekar, V, et al.
Publicado: (2010)

Health-related quality of life (HRQoL) assessment with once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial
por: Spinosa-Guzman, S, et al.
Publicado: (2010)

Atopy in cutaneous and arthropatic psoriasis
por: Hajdarbegovic, E, et al.
Publicado: (2010)

Improving team work during bedside rounds: using daily goals and best practices
por: Adamson, M, et al.
Publicado: (2010)

Standard operating procedures in postresuscitation care: facilitated realisation therapeutic measures in daily practice
por: Busch, HJ, et al.
Publicado: (2008)

P034: Daily observation rounds to assess the practice for patients isolated because of diarrhea
por: Mikkelsen, R, et al.
Publicado: (2013)

Severe erytrodermic psoriasis and arthritis as clinical presentation of a CARD14-mediated psoriasis (CAMPS)
por: Signa, S, et al.
Publicado: (2015)

A comparison of the FDA TLOVR and FDA Snapshot algorithms based on studies evaluating once-daily vs. twice daily lopinavir/ritonavir (LPV/r) regimens
por: Qaqish, R, et al.
Publicado: (2010)

Delirium assessment in daily critical care with the CAM-ICU: a multicenter study
por: Van Eijk, MM, et al.
Publicado: (2011)

Treatment of refractory juvenile dermatomyositis with tacrolimus
por: Hassan, J, et al.
Publicado: (2008)

PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis
por: Bellutti Enders, F, et al.
Publicado: (2013)

Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients—A BioCAPTURE Registry Study
por: ter Haar, E. L. M., et al.
Publicado: (2022)

Exercise limitation in juvenile onset Mixed Connective Tissue Disease (MCTD)
por: Net, JJ van der, et al.
Publicado: (2008)

Influence of demographic and disease parameters on virological response to once- vs twice-daily darunavir/ritonavir (DRV/r) at week 48 in ODIN
por: Sension, M, et al.
Publicado: (2010)

Demonstration of novel innate immune cells in psoriasis
por: Mak, R, et al.
Publicado: (2010)

Appraisal of the daily clinical rounds performed in an open and general ICU
por: Filho, Roberto R, et al.
Publicado: (2015)

Poster 2004: Bio Immun(G)En medicine or how to link scientific research and daily therapeutic practice
por: Glady, Gilbert
Publicado: (2014)

The 10 year safety and efficacy of tenofovir disoproxil fumarate (TDF)-containing once-daily highly active antiretroviral therapy (HAART)
por: Cassetti, I, et al.
Publicado: (2010)

Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir
por: Nozza, S, et al.
Publicado: (2010)

5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF)
por: Lazzarin, A, et al.
Publicado: (2010)

Image‐based automated Psoriasis Area Severity Index scoring by Convolutional Neural Networks
por: Schaap, M.J., et al.
Publicado: (2021)

Inter-rater agreement of an alternative guideline for the assessment of the activities of daily living in home nursing
por: Paquay, Louis, et al.
Publicado: (2015)

HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
por: van den Kerkhof, Tom, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_an2rv4t5tqg307vhe48eb2v7qd